| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |